DarioHealth (DRIO) Misses Q2 EPS by 14c

DarioHealth (NASDAQ: DRIO) reported Q2 EPS of ($0.99), $0.14 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $5.11 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• SanDisk upgraded at JPMorgan after investor day; shares climb